Document is current
Any future updates will be listed below
-
Authors
Rodríguez Sagrado, Miguel Angel https://orcid.org/0000-0002-3283-9332
Alvarez Criado, Javier
Arenaza Peña, Ainhoa Elisa
Escudero-Vilaplana, Vicente
Folguera Olias, Carlos
Herrero Fernandez, Marta
Martinez Nieto, Concepción
Rubio Salvador, Ana Rosa
Sanmartin Fenollera, Patricia
Vazquez Castillo, Maria José
-
Funding
Funding for this research was provided by:
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors
- License Information
-
More Information
Article History
Accepted: 12 December 2024
First Online: 24 January 2025
Declarations
:
: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
: All authors (M.A.R.S., J.A.C., A.E.A.P., V.E.V., C.F.O., M.H.F., C.M.N., A.R.R.S., P.S.F., and M.J.V.C.) declare that they have carried out activities remunerated by GlaxoSmithKline (GSK; participation in conferences, scientific meetings, etc.), without representing competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
: The study was approved by the ethics committee in May 2022 with an exception from informed consent. The study was conducted in accordance with the Declaration of Helsinki and the International Conference on Harmonization and Good Clinical Practice standards.
: Not applicable.
: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
: Not applicable.
: All authors participated in conceptualization, data curation, formal analysis, and writing, review, and approval of the final version of the manuscript.
